158 related articles for article (PubMed ID: 7647158)
1. Factors influencing efficacy of exogenous surfactant in acute lung injury.
Lewis JF; Veldhuizen RA
Biol Neonate; 1995; 67 Suppl 1():48-60. PubMed ID: 7647158
[TBL] [Abstract][Full Text] [Related]
2. Surfactant: current and potential therapeutic application in infants and adults.
Lewis J; Veldhuizen RA
J Aerosol Med; 1996; 9(1):143-54. PubMed ID: 10160204
[TBL] [Abstract][Full Text] [Related]
3. Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury.
Lewis JF; McCaig L
Am Rev Respir Dis; 1993 Nov; 148(5):1187-93. PubMed ID: 8239152
[TBL] [Abstract][Full Text] [Related]
4. The role of exogenous surfactant in the treatment of acute lung injury.
Lewis JF; Veldhuizen R
Annu Rev Physiol; 2003; 65():613-42. PubMed ID: 12517997
[TBL] [Abstract][Full Text] [Related]
5. Surfactant and the adult respiratory distress syndrome.
Lewis JF; Jobe AH
Am Rev Respir Dis; 1993 Jan; 147(1):218-33. PubMed ID: 8420422
[TBL] [Abstract][Full Text] [Related]
6. [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].
Lauer S; Fischer LG; Stubbe HD; Van Aken H; Westphal M
Anaesthesist; 2006 Apr; 55(4):433-42. PubMed ID: 16440205
[TBL] [Abstract][Full Text] [Related]
7. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
[TBL] [Abstract][Full Text] [Related]
8. Surfactant replacement therapy for adult respiratory distress syndrome in children.
Evans DA; Wilmott RW; Whitsett JA
Pediatr Pulmonol; 1996 May; 21(5):328-36. PubMed ID: 8726159
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of exogenous surfactant in HCL-induced lung injury.
Brackenbury AM; Puligandla PS; McCaig LA; Nikore V; Yao LJ; Veldhuizen RA; Lewis JF
Am J Respir Crit Care Med; 2001 Apr; 163(5):1135-42. PubMed ID: 11316649
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized and instilled surfactant therapies for acute lung injury caused by intratracheal endotoxin in rats.
Tashiro K; Yamada K; Li WZ; Matsumoto Y; Kobayashi T
Crit Care Med; 1996 Mar; 24(3):488-94. PubMed ID: 8625639
[TBL] [Abstract][Full Text] [Related]
11. Surfactant therapy in adults with acute lung injury/acute respiratory distress syndrome.
Kesecioglu J; Haitsma JJ
Curr Opin Crit Care; 2006 Feb; 12(1):55-60. PubMed ID: 16394785
[TBL] [Abstract][Full Text] [Related]
12. [Surfactant replacement therapy increases life-span of patients with acute respiratory distress syndrome].
Potapov AL; Novikov NIu; Tumanskiĭ VA; Babanin AA
Klin Khir; 2013 Feb; (2):57-9. PubMed ID: 23705485
[TBL] [Abstract][Full Text] [Related]
13. Tracheal acid or surfactant instillation raises alveolar surface tension.
Nguyen TL; Perlman CE
J Appl Physiol (1985); 2018 Nov; 125(5):1357-1367. PubMed ID: 29771610
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
Häfner D; Ibrahim M; Wollin L; Germann PG
Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630
[TBL] [Abstract][Full Text] [Related]
15. Exogenous surfactant in paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome.
Playfor SD; Nootigattu VK
Curr Drug Saf; 2006 May; 1(2):159-68. PubMed ID: 18690927
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury.
Lewis JF; Goffin J; Yue P; McCaig LA; Bjarneson D; Veldhuizen RA
J Appl Physiol (1985); 1996 Apr; 80(4):1156-64. PubMed ID: 8926241
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
[TBL] [Abstract][Full Text] [Related]
18. Consensus on surfactant and inhaled nitric oxide for ARDS.
Gadek JE
J Aerosol Med; 1996; 9(1):155-62. PubMed ID: 10160205
[TBL] [Abstract][Full Text] [Related]
19. Role of surfactant in the pathophysiology of the acute respiratory distress syndrome (ARDS).
Hartog A; Gommers D; Lachmann B
Monaldi Arch Chest Dis; 1995 Oct; 50(5):372-7. PubMed ID: 8541821
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury. Impact on gas exchange.
Schermuly R; Schmehl T; Günther A; Grimminger F; Seeger W; Walmrath D
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):445-53. PubMed ID: 9279222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
